Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6223223rdf:typepubmed:Citationlld:pubmed
pubmed-article:6223223lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:6223223lifeskim:mentionsumls-concept:C0229664lld:lifeskim
pubmed-article:6223223lifeskim:mentionsumls-concept:C0039194lld:lifeskim
pubmed-article:6223223lifeskim:mentionsumls-concept:C0079720lld:lifeskim
pubmed-article:6223223lifeskim:mentionsumls-concept:C0038952lld:lifeskim
pubmed-article:6223223pubmed:issue2lld:pubmed
pubmed-article:6223223pubmed:dateCreated1983-8-11lld:pubmed
pubmed-article:6223223pubmed:abstractTextHuman peripheral blood T lymphocyte subpopulations were identified and isolated on the basis of their ability to bind IgG (T-G), IgM (T-M), or neither immunoglobulin class (T-null). Lymphocytes were exposed to 0, 0.5, 1.0, 2.5 or 5.0 Gy of 60Co gamma-rays either as a T-cell suspension or as separated T cell subsets. Survival curves, determined 5 days after irradiation, revealed that each subset has radiosensitive and radioresistant portions, and that the T-G cell is the most sensitive subset. Mitotic indices of 48-h cultures showed that the response of unirradiated T lymphocytes to PHA varied greatly among the subsets, the highest indices being obtained for the T-M and the lowest for the T-G cells. With the possible exception of the T-G cells, the subsets are relatively resistant to mitotic effects of gamma-rays. T-G cells suppress the PHA-induced mitotic response of the other T lymphocyte subsets, and this suppressor effect is radiosensitive, being abolished by 1.0 Gy. It is concluded that lymphocytes exposed to greater than or equal to 1 Gy of gamma-rays will have very few dividing B lymphocytes or T-G cells. This together with radiation-induced loss of T-G suppressor action means that the predominant lymphocyte types in mitosis after greater than or equal to 1 Gy are the radioresistant T-M and T-null cells.lld:pubmed
pubmed-article:6223223pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6223223pubmed:languageenglld:pubmed
pubmed-article:6223223pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6223223pubmed:citationSubsetIMlld:pubmed
pubmed-article:6223223pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6223223pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6223223pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6223223pubmed:statusMEDLINElld:pubmed
pubmed-article:6223223pubmed:monthFeblld:pubmed
pubmed-article:6223223pubmed:issn0027-5107lld:pubmed
pubmed-article:6223223pubmed:authorpubmed-author:SchwartzJ LJLlld:pubmed
pubmed-article:6223223pubmed:authorpubmed-author:GauldenM EMElld:pubmed
pubmed-article:6223223pubmed:authorpubmed-author:DarrJ CJClld:pubmed
pubmed-article:6223223pubmed:issnTypePrintlld:pubmed
pubmed-article:6223223pubmed:volume107lld:pubmed
pubmed-article:6223223pubmed:ownerNLMlld:pubmed
pubmed-article:6223223pubmed:authorsCompleteYlld:pubmed
pubmed-article:6223223pubmed:pagination413-25lld:pubmed
pubmed-article:6223223pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:6223223pubmed:meshHeadingpubmed-meshheading:6223223-...lld:pubmed
pubmed-article:6223223pubmed:meshHeadingpubmed-meshheading:6223223-...lld:pubmed
pubmed-article:6223223pubmed:meshHeadingpubmed-meshheading:6223223-...lld:pubmed
pubmed-article:6223223pubmed:meshHeadingpubmed-meshheading:6223223-...lld:pubmed
pubmed-article:6223223pubmed:meshHeadingpubmed-meshheading:6223223-...lld:pubmed
pubmed-article:6223223pubmed:meshHeadingpubmed-meshheading:6223223-...lld:pubmed
pubmed-article:6223223pubmed:meshHeadingpubmed-meshheading:6223223-...lld:pubmed
pubmed-article:6223223pubmed:meshHeadingpubmed-meshheading:6223223-...lld:pubmed
pubmed-article:6223223pubmed:meshHeadingpubmed-meshheading:6223223-...lld:pubmed
pubmed-article:6223223pubmed:meshHeadingpubmed-meshheading:6223223-...lld:pubmed
pubmed-article:6223223pubmed:year1983lld:pubmed
pubmed-article:6223223pubmed:articleTitleSurvival and PHA-stimulation of gamma-irradiated human peripheral blood T lymphocyte subpopulations.lld:pubmed
pubmed-article:6223223pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6223223pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:6223223pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:6223223pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6223223lld:pubmed